Quince Therapeutics Inc

NASDAQ:QNCX   4:00:00 PM EDT
1.50
-0.03 (-1.96%)
: $1.50 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Quince Therapeutics Inc Stock, NASDAQ:QNCX

601 Gateway Boulevard, Suite 1250, South San Francisco, California 94080
United States of America
Phone: +1.650.910.5717
Number of Employees: 21
http://quincetx.com

Description

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline consists of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.